Diagnosis and management of amiodarone‐induced thyrotoxicosis: similarities and differences between North American and European thyroidologists *

Objective  To investigate how North American thyroidologists assess and treat amiodarone‐induced thyrotoxicosis (AIT) and to compare the results with those of the same questionnaire‐based survey previously carried out among European thyroidologists.

[1]  F. Bogazzi,et al.  Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study , 2007, Langenbeck's Archives of Surgery.

[2]  J. Franklyn,et al.  Treatment of amiodarone-associated thyrotoxicosis , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[3]  M. Piga,et al.  Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis , 2007, Acta radiologica.

[4]  F. Bogazzi,et al.  Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. , 2007, The Journal of clinical endocrinology and metabolism.

[5]  J. Romaldini,et al.  Management of amiodarone‐induced thyrotoxicosis in Latin America: an electronic survey , 2006, Clinical endocrinology.

[6]  A. Pinchera,et al.  Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis , 2006, Journal of endocrinological investigation.

[7]  A. O’Sullivan,et al.  Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. , 2006, European journal of endocrinology.

[8]  W. Wiersinga,et al.  Diagnosis and management of amiodarone‐induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association , 2004, Clinical endocrinology.

[9]  R. Kloos,et al.  Can amiodarone be restarted after amiodarone-induced thyrotoxicosis? , 2004, Thyroid : official journal of the American Thyroid Association.

[10]  L. Bartalena.  The dilemma of non-thyroidal illness syndrome: to treat or not to treat? , 2003, Journal of endocrinological investigation.

[11]  A. Pinchera,et al.  The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. , 2003, Thyroid : official journal of the American Thyroid Association.

[12]  A. Pinchera,et al.  Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis , 2003, Journal of endocrinological investigation.

[13]  A. Pinchera,et al.  Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. , 2003, The Journal of clinical endocrinology and metabolism.

[14]  M. Erdoğan,et al.  A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis. , 2003, Thyroid : official journal of the American Thyroid Association.

[15]  Mathew R. Williams,et al.  Thyroidectomy using local anesthesia in critically ill patients with amiodarone-induced thyrotoxicosis: a review and description of the technique. , 2002, Thyroid : official journal of the American Thyroid Association.

[16]  J. Franklyn,et al.  Successful Treatment of Amiodarone-Induced Thyrotoxicosis , 2002, Circulation.

[17]  A. Pinchera,et al.  Iopanoic acid rapidly controls Type I amiodarone-induced thyrotoxicosis prior to thyroidectomy , 2002, Journal of endocrinological investigation.

[18]  A. Weetman,et al.  Clinical experience of amiodarone‐induced thyrotoxicosis over a 3‐year period: role of colour‐flow Doppler sonography * , 2002, Clinical endocrinology.

[19]  F. Bogazzi,et al.  Amiodarone‐induced thyrotoxicosis: a difficult diagnostic and therapeutic challenge * , 2002, Clinical endocrinology.

[20]  L. Braverman,et al.  The various effects of amiodarone on thyroid function. , 2001, Thyroid : official journal of the American Thyroid Association.

[21]  L. Braverman,et al.  The effects of amiodarone on the thyroid. , 2001, Endocrine reviews.

[22]  A. Weetman,et al.  Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy , 1998, Heart.

[23]  F. Bogazzi,et al.  Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. , 1996, The Journal of clinical endocrinology and metabolism.

[24]  W. Wiersinga,et al.  Two cases of amiodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued. , 1994, British heart journal.

[25]  L. Braverman,et al.  Serum interleukin-6 in amiodarone-induced thyrotoxicosis. , 1994, The Journal of clinical endocrinology and metabolism.

[26]  L. Braverman,et al.  Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid. , 1993, Archives of internal medicine.

[27]  G. Gavaruzzi,et al.  Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis. , 1992, The Journal of clinical endocrinology and metabolism.

[28]  J. A. Franklyn,et al.  Treatment of amiodarone induced thyrotoxicosis with carbimazole alone and continuation of amiodarone. , 1992, BMJ.

[29]  L. Braverman,et al.  Thyroidectomy for amiodarone-induced thyrotoxicosis. , 1990, Journal of the American Medical Association (JAMA).

[30]  A. Pinchera,et al.  Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole , 1986, Journal of endocrinological investigation.

[31]  C. Haffajee,et al.  Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. , 1984, Annals of internal medicine.

[32]  K. Chung,et al.  AMIODARONE AND THE THYROID , 1979, The Lancet.

[33]  L. Bartalena.  The dilemma of non-thyroidal illness: to treat or not to treat? , 2003 .

[34]  Guy E. Thwaites,et al.  The Diagnosis and Management of Tuberculous Meningitis , 2002, Practical Neurology.